Skin Angiosarcoma — Clinical Trials

MONDO:00030293 active·1 recruitingLast updated: Mar 19, 2026, 3:30 PM

Trial Landscape

Skin Angiosarcoma has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment3

Procedure1

Biological Therapy1

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 2

Sponsor Types

Academic/Other2NIH1

Trial Locations

United States2 trials

Guam1 trial

Japan1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT06673628

Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients

Sponsor:National Cancer Center, Japan

JapanStarted: Dec 2024Est. completion: Nov 2029Updated: Nov 2025

Phase 2Active, Not Recruiting

NCT04339738

Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Nov 2020Est. completion: Jan 2027Updated: Feb 2026

Phase 2Active, Not Recruiting

NCT03069378

A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Sponsor:Memorial Sloan Kettering Cancer Center

United StatesStarted: Mar 2017Est. completion: Mar 2026Updated: Oct 2025

Stay informed about clinical trials for Skin Angiosarcoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 3:30 PM